• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

tirzepatide

Novo Nordisk
Marketing

Rybelsus brand retired in US as ‘Ozempic pill’ takes the stage

The semaglutide franchise is changing up its branding as Novo Nordisk is retiring the Rybelsus name in favor of its better-known brand.
Ben Adams , Fraiser Kansteiner May 1, 2026 8:00am
Eli Lilly Lilly

Lilly warns of 'impurity' in some compounded tirzepatide drugs

Mar 12, 2026 10:00am
Red computer key with a warning symbol on it

FDA unleashes warning letters to firms selling compounded GLP-1s

Mar 4, 2026 8:30am
Heart-shaped stone in a zen garden
Favicon Fierce Biotech

How GLP-1s help the heart relax: study

Mar 2, 2026 7:01pm
Eli Lilly

Lilly touts Zepbound-Taltz combo in patients with obesity, PsA

Jan 8, 2026 2:00pm
White House

Lilly, Novo reach GLP-1 pricing deals with White House

Nov 6, 2025 12:26pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings